Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Penack

Showing results (101-110 of 184) with videos related to

Pageof 19
Sort By:
Frontiers in Immunology|November 15, 2023
Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-α signalingGuido Moll, Christian Luecht, Michael Adu Gyamfi, et al.
Annals of Hematology|September 13, 2013
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Sabine Mousset, Dieter Buchheidt, Werner Heinz, et al.
Bone Marrow Transplantation|August 19, 2025
Post-transplantation cyclophosphamide and antithymocyte globulin in 8/10 HLA-mismatched unrelated donor transplantation: the analysis on behalf of the transplant complications working party of the EBMTIvan Moiseev, Mouad Abouqateb, Christophe Peczynski, et al.
Bone Marrow Transplantation|December 7, 2023
The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working PartyLars Klingen Gjærde, Tapani Ruutu, Christophe Peczynski, et al.
Journal for Immunotherapy of Cancer|May 17, 2022
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCLKai Rejeski, Ariel Perez, Gloria Iacoboni, et al.
Bone Marrow Transplantation|October 24, 2021
HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working PartyMalgorzata Mikulska, Olaf Penack, Lotus Wendel, et al.
Bone Marrow Transplantation|April 9, 2025
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines CommitteeGuillermo Ortí, Guillaume Dachy, Charlotte E Graham, et al.
Annals of Hematology|September 30, 2020
Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)Boris Böll, Enrico Schalk, Dieter Buchheidt, et al.
Nature Communications|September 30, 2024
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cellsTobias Bexte, Nawid Albinger, Ahmad Al Ajami, et al.
Bone Marrow Transplantation|June 18, 2024
Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working partyHélène Schoemans, Linda J Burns, Sarah J Liptrott, et al.
Pageof 19

Showing results (101-110 of 184) with videos related to

Sort By:
Pageof 19
Frontiers in Immunology|November 15, 2023
Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-α signalingGuido Moll, Christian Luecht, Michael Adu Gyamfi, et al.
Annals of Hematology|September 13, 2013
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Sabine Mousset, Dieter Buchheidt, Werner Heinz, et al.
Bone Marrow Transplantation|August 19, 2025
Post-transplantation cyclophosphamide and antithymocyte globulin in 8/10 HLA-mismatched unrelated donor transplantation: the analysis on behalf of the transplant complications working party of the EBMTIvan Moiseev, Mouad Abouqateb, Christophe Peczynski, et al.
Bone Marrow Transplantation|December 7, 2023
The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working PartyLars Klingen Gjærde, Tapani Ruutu, Christophe Peczynski, et al.
Journal for Immunotherapy of Cancer|May 17, 2022
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCLKai Rejeski, Ariel Perez, Gloria Iacoboni, et al.
Bone Marrow Transplantation|October 24, 2021
HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working PartyMalgorzata Mikulska, Olaf Penack, Lotus Wendel, et al.
Bone Marrow Transplantation|April 9, 2025
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines CommitteeGuillermo Ortí, Guillaume Dachy, Charlotte E Graham, et al.
Annals of Hematology|September 30, 2020
Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)Boris Böll, Enrico Schalk, Dieter Buchheidt, et al.
Nature Communications|September 30, 2024
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cellsTobias Bexte, Nawid Albinger, Ahmad Al Ajami, et al.
Bone Marrow Transplantation|June 18, 2024
Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working partyHélène Schoemans, Linda J Burns, Sarah J Liptrott, et al.
Pageof 19